🔎 Trials Near Me

Akèy › Miasteni grav › Texas › Houston

Etid klinik pou Miasteni grav nan Houston, TX

11 etid pou Miasteni grav ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

Ap rekriteFaz 3
  • Cinical Study Site, Houston
Laj 18 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT07647510

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Ap rekriteFaz 2
  • Nerve and Muscle Center of Texas - Neurology, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07501702

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Ap rekriteFaz 1/2
  • Baylor College of Medicine Neurology Department, Houston
  • Houston Methodist Hospital, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Laj 18 a 70 · Tout sèks · Mizajou Aug 13, 2026 · NCT06359041

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Ap rekriteFaz 1/2
  • Aurinia Investigational Site, Houston
Laj 18 a 85 · Tout sèks · Mizajou Aug 3, 2026 · NCT07596901

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Ap rekriteFaz 3
  • Site Number - 1057, Houston
Laj 18 a 80 · Tout sèks · Mizajou Jul 30, 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Ap rekriteFaz 2/3
  • Houston Methodist Hospital, Houston
Laj 18 a 75 · Tout sèks · Mizajou Jul 29, 2026 · NCT06193889

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Ap rekriteFaz 3
  • Houston Methodist Neurological Institute, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT06456580

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Ap rekriteFaz 1
  • Houston Methodist Hospital, Houston
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT06626919

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Ap rekriteEtid obsèvasyon
  • Clinical Trial Site, Houston
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT04202341

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Ap rekriteFaz 1/2
  • Nerve & Muscle Center of Texas, Houston
  • Houston Methodist Neurological Institute, Houston
Laj 18 a 74 · Tout sèks · Mizajou Feb 11, 2026 · NCT07250750

Vitaccess Real MG Registry

Ap rekriteEtid obsèvasyon
  • University of Texas Health Science Center at Houston, Houston
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2025 · NCT06064461

Etid Miasteni grav nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.